Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors

Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof: Formula (I). Also disclosed herein are uses of the compounds disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions compri...

Full description

Saved in:
Bibliographic Details
Main Authors Li, Guoqing, Achab, Abdelghani, Li, Derun, Yu, Wensheng, Shi, Zhi-Cai, Zhang, Hongjun, Guo, Liangqin, He, Shuwen, Liu, Kun, Deng, Yongqi, Han, Yongxin, Fradera, Xavier, Kozlowski, Joseph, Biju, Purakkattle, Pu, Qinglin, Cernak, Timothy A
Format Patent
LanguageEnglish
Published 27.04.2021
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof: Formula (I). Also disclosed herein are uses of the compounds disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.
Bibliography:Application Number: US201716326408